ferric hydroxide-polymaltose
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
2
Earliest trial started Jun 1, 2015 (NCT02487719)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Mechanism of action
- IronSupplementation
Iron supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ferric hydroxide-polymaltose
- ferric polymaltose
- ferripolyisomaltose
- ferrum hausmann
- intrafer
- iron hydroxide polymaltose
- iron(iii)-hydroxide-dextrin
- iron polymaltose
- iron polymaltose
- iron polymaltose
- iron-polymaltose complex
- noripurum
- teferrol
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03993288 | Phase 3 | Jun 28, 2019 | Sandoz |
| NCT03748043 | Phase 4 | Feb 21, 2019 | South Valley University |
| NCT02487719 | Phase 4 | Jun 1, 2015 | University of Zurich |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sandoz | For profit | 1 | 1 | 1 | 2019 |
| South Valley University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| University of Zurich | Academic/Hospital | 1 | 1 | 1 | 2015 |
3 organizations
Page 1 / 1